By in situ hybridization we show that the L-12LO gene is expressed abundantly in a subset of peritoneal macrophages but not in elicited leukocytes, alveolar macrophages, or bone marrow-derived macrophages. L-12LO is highly related to human and rabbit 15-lipoxygenases, enzymes that have been implicated in the maturation process of red blood cells, and the oxidative modification of low density lipoproteins that is implicated in atherogenesis. Accordingly, these enzymes have been referred to as 12/15-lipoxygenases. We have inactivated the L-12LO gene in mice using homologous recombination in embryonic stem cells. Macrophage expression of L-12LO was abolished in homozygous deficient mice as was formation of 12-hydroxyeicosatetraenoic acid (12-HETE). In zymosan-stimulated cells, there was significant diversion of metabolism to the 5-lipoxygenase products leukotriene C 4 and 5-HETE and in A23187-treated cells to 5-HETE only. The enhanced formation of 5-lipoxygenase metabolites was not due to compensatory changes of 5-lipoxygenase or 5-lipoxygenase activating protein but rather an apparent substrate diversion. L-12LO-deficient mice have no obvious abnormalities in reticulocyte or mature red blood cells, which suggest that in mice this pathway is not functionally important for erythrocytic development. Indices for oxidation of low density lipoprotein (measured as either thiobarbituric acid-reactive substances or the oxidant stress marker isoprostane 8-epi-prostaglandin F 2␣ ) were identical in incubations with unstimulated wild-type and L-12LO-deficient macrophages, but the zymosan-induced increase observed with wild-type macrophages was abolished in L-12LO-deficient cells. Thus, 12/15-lipoxygenase-deficient mice will be useful for the study of interaction between lipoxygenase pathways and determination of the in vivo role of 12/15-lipoxygenase-catalyzed oxidation of LDL in atherogenesis.
12-Lipoxygenase incorporates stereospecifically molecular oxygen into arachidonic acid to form 12-hydroperoxyeicosatetraenoic acid (12-HPETE). 1 Two types of 12-lipoxygenase enzymes have been described that differ biochemically and in immunoreactivity (1, 2) . The primary sequences are 58 -65% identical based on the cloned cDNA sequence data (3) (4) (5) . Enzyme activity for the "platelet-type" 12-lipoxygenase (P-12LO) was first found in human platelets more than 20 years ago (6) . P-12LO has been found to be the predominant isoform in epidermal skin specimens and A431 epidermoid cells (5, (7) (8) (9) . The other 12-lipoxygenase, referred to as "leukocyte-type," was first characterized extensively from porcine leukocytes (10) and was found to have a rather broad distribution in porcine and canine tissues by immunochemical assays (11, 12) . Besides tissue distribution, the leukocyte-type 12-lipoxygenase (L-12LO) is distinguished from the platelet-type enzyme by its ability to form 15-HPETE in addition to 12-HPETE from arachidonic acid substrate. L-12LO is highly related to 15LO in that both are dual specificity lipoxygenases, and they are about 85% identical in primary structure in higher mammals (excluding rodent sequences) (5, 13, 14) . L-12LO and 15LO have not yet been shown conclusively to co-exist within the same species at the molecular level, so it has been postulated that the 15LO found in human reticulocytes, airway epithelium, and eosinophils is the species equivalent of the L-12LO's found in bovine tracheal epithelium, porcine leukocytes, and mouse macrophages (5, 14 -17) .
The biological functions of these so-called 12/15-lipoxygenases are poorly understood. This is partly due to the lack of specific, potent inhibitors for these pathways. The 15LO of rabbit reticulocytes has been proposed to oxygenate membrane lipids in a step leading to intracellular organelle degradation and erythrocyte maturation (18, 19) . This pathway has also been implicated in the oxidative modification of LDL (20, 21) , a process believed important in foam cell development and atherosclerosis. To explore potential roles for the 12/15-lipoxygenase, we describe the development of L-12LO-deficient mice and focus primarily on the role and expression of this pathway in different types of macrophages.
EXPERIMENTAL PROCEDURES
Preparation of Macrophages-Resident peritoneal macrophages (PM) were collected after -intraperitoneal injection of 5 ml of Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (complete medium), washed once with phosphate-buffered saline (PBS), resuspended in complete medium, and plated onto culture dishes. After 2 h at 37°C in a 95% air, 5% CO 2 incubator, the macrophages were washed twice with DMEM to remove nonadherent cells.
Alveolar macrophages (AM) were harvested by bronchoalveolar lavage with five 1-ml rinses of complete medium at 37°C and prepared as above for PM.
Bone marrow-derived macrophages (BM) were obtained from marrow plugs flushed from femurs with 2.5 ml of ice-cold complete medium supplemented with 2 mM glutamine, 100 units/ml penicillin, 100 g/ml streptomycin. After centrifugation at 1200 rpm (Jouan CR422) for 5 min, the pellet was resuspended in fresh DMEM with 20% fetal bovine serum and 30% L929 cell-conditioned medium, dispersed by three passes through a 30-gauge needle, and the cells (3.2 ϫ 10 5 /ml) seeded onto 100-mm non-tissue culture dishes and incubated at 37°C in a 95% air, 5% CO 2 incubator for 5-7 days. After 5 days incubation, cells were rinsed and stimulated as follows for 48 h: murine recombinant IL-4 (100 pM, 500 pM; Life Technologies, Inc., 10 7 units/mg), LPS (100 ng/ml; Sigma, from Salmonella enteritidis), murine recombinant IFN-␥ (500 units/ml; Genzyme Diagnostics, 10 7 units/mg), recombinant mouse IL-2 (10 units/ml; Genzyme Diagnostics, 2.5 ϫ 10 6 units/mg), mouse tumor necrosis factor-␣ (400 units/ml; Boehringer Mannheim, 6 ϫ 10 7 units/ mg), recombinant murine IL-13 (5 ng/ml; R & D Systems, Inc.). The cells were characterized by nonspecific esterase activity and morphology.
In Situ Hybridization-PM, AM, and BM were cytospun onto Probe-On Plus slides (Fisher) at 4 ϫ 10 5 cells/ml, 200 l/slide for 5 min at 550 rpm (Shandon cytospin centrifuge). The macrophages were fixed immediately with 4% paraformaldehyde at 4°C for 15 min, washed with diethylpyrocarbonate-treated PBS three times, and air-dried for 5 min. The slides were used either immediately or stored at Ϫ70°C. The slides were soaked in 2 ϫ SSC at room temperature for 10 min, exposed to UV light for 5 min, and incubated with prehybridization solution (0.6 M NaCl, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, pH 8.0, 50% formamide, 2.5 ϫ Denhardt's solution, 0.5 mg/ml sonicated salmon sperm DNA, 50 g/ml yeast tRNA) at 50°C for 1 h. The solution was gently removed, and 300 l of hybridization solution (prehybridization solution plus 10% dextran sulfate and 10 mM dithiothreitol) containing L-12LO riboprobe (see below) was added. After hybridization at 50°C overnight, the slides were washed with 2 ϫ SSC for 1 h at the same temperature, incubated with 50 g/ml RNase I at 37°C for 1 h, rewashed, and a final overnight wash in 0.1 ϫ SSC, 0.1% ␤-mercaptoethanol, 0.05% Na 4 P 2 O 7 ) was performed. After dehydration in ethanol, the slides were coated with emulsion (Kodak NTB-2, 0.5 ϫ concentrated), exposed at 4°C for 7 days, developed, and stained with Wright's Giemsa.
RNA Probe Preparation-A 1.2-kb L-12LO cDNA (nucleotides Ϫ3 to 1182) cloned in pCRII (Invitrogen) was linearized with SpeI or XhoI and incubated with T7 (antisense) or SP6 (sense) RNA polymerase, respectively, and [ 33 P]UTP under standard in vitro transcription procedures (22) . After DNase I digestion, the probe was subjected to limited alkaline hydrolysis to Ϸ200 nucleotide fragments, neutralized, ethanolprecipitated, and dissolved in 50 l of 0.1 M dithiothreitol.
Preparation of Gene Targeting Vector-The complete mouse L-12LO gene was cloned previously (5) from a strain 129 Sv genomic library. A 6.9-kb XbaI fragment was excised and cloned into pGEM3zf(Ϫ) (Promega). A blunt-ended neo cassette under control of the polII promoter and 3Ј bovine growth hormone polyadenylation sequence (23) was inserted into the StuI site within exon 3 (see Fig. 2 ). Actually, during the cloning process into the blunt-ended site, only one clone was obtained that contained two neomycin cassettes in reverse orientation. A thymidine kinase cassette cleaved from pMC1-TK (obtained from B. Hogan, Vanderbilt University) with XhoI and inserted into the SalI site in the polylinker was introduced for negative selection. The plasmid was linearized with a SalI site within the polylinker of pMC1-TK.
Generation of L-12LO-deficient Mice-DNA (25 g) was electroporated into D3H mouse embryonic stem cells as described previously (24) . After 8 days selection in G418 (300 g/ml) and ganciclovir (2 M; gift of Syntex, Inc., Palo Alto, CA) colonies were picked, placed in 96-well plates, and processed for cell freezing and DNA Southern blot analysis as described by Ramirez-Solis et al. (25) . The DNA was digested with StuI/BamHI, electrophoresed in a 1% agarose/TAE (Tris acetate EDTA) gel, blotted to nylon membrane, and hybridized with a random prime 32 P-labeled 240-base pair fragment external to the targeting vector (probe A, Fig. 2 ). Hybridization to a 10-kb band, in addition to the wild-type 5.4-kb band, was indicative of targeted events. Clones exhibiting the proper targeting were subjected to further analysis with probes A, B, or neo and other restriction digests. Targeted embryonic stem cells (10 -15) were injected into 3.5 day C57BL/6 blastocysts, and the embryos were transferred into ICR pseudopregnant recipients. Male chimera (evidence of agouti coat color) offspring were mated with C57BL/6 females to obtain germ line transmitting progeny. All mice used in these studies were a mixed C57BL/6 ϫ 129 Sv genetic background.
RNA Blot Analysis-Total RNA was isolated from macrophages by the method of Chomczynski and Sacchi (26) and was electrophoresed in a 1% agarose/formaldehyde gel as described (27) , blotted to nitrocellulose membrane (Hybond-C, Amersham Corp.), and hybridized with a random prime 32 P-labeled L-12LO probe (same fragment of cDNA as mentioned above) and human glyceraldehyde 3-phosphate dehydrogenase probe (Ambion).
Immunoblot Analysis-Macrophages were sonicated in PBS containing 1 mM phenylmethylsulfonyl fluoride and 60 g/ml soybean trypsin inhibitor, and homogenate protein was subjected to electrophoresis in 10 or 12% SDS-polyacrylamide mini-gels with a stacking layer. The protein was electroblotted to Hybond EC nitrocellulose and probed with an anti-mouse L-12LO antiserum (5) (28) . Labeled samples were extracted with ODS-silica columns (Millipore) and separated by RP-HPLC using a Phenomenex ODS-silica column (5-m particle size; 25 ϫ 0.3 cm) and a solvent system consisting of MeCN/MeOH/H 2 O/trifluoroacetic acid (37.5:25:37.5:0.05) at a flow rate of 0.75 ml/min with UV detection first at 280 nm for detection of leukotrienes and then switched to 235 nm for HETE detection using a Hewlett-Packard Series 1050 HPLC system and HP Chem Station for LC data analysis program. Integrated peak areas were compared with standard curves prepared from known amounts of 5-HETE, 12-HETE, 15-HETE, and leukotriene C 4 (Cayman Chemical Co., Ann Arbor, MI). Radioactivity in 1-min fractions was detected by scintillation counting.
Blood Cell Data-Blood (Ϸ100 l) was drawn from the retro-orbital plexus of lightly ether-anesthetized 8-week-old mice into heparinized microhematocrit tubes and diluted with 4 volumes PBS/EDTA (2 mM). The blood cells were subjected to automated cell analysis with a Technicon H1 electronic cell counter (Miles, Inc.). Leukocyte differentials were performed on blood smears stained with Wright's Giemsa (Sigma), and reticulocyte counts were performed on blood samples placed immediately in new methylene blue stain. For platelet incubations, blood was obtained by cardiac puncture, centrifuged at 100 ϫ g, the platelet-rich plasma collected and spun at 1000 ϫ g. The cell pellet was washed once with Tyrode's buffer and the cells suspended in PBS.
Inflammation Experiments-Experiments to measure mouse ear swelling with arachidonic acid or phorbol myristate acetate and influx of neutrophils to nonspecific glycogen challenge were performed as described previously (24) .
Peritoneal Macrophage Functional Assays-Nitric oxide production was measured with Greiss reagents, and spectrophotometric readings were performed at 540 nm with sodium nitrite as standard (29) . Mannose receptor activity was measured (30) as the ability to internalize the mannose-containing protein horseradish peroxidase. Rosette and phagocytosis assays were performed essentially as described (31) . Phagocytosis was assessed also by the ability to uptake opsonized Texas Redconjugated yeast BioParticles (Molecular Probes; 25:1 particles/cell) as described by de Lanerolle et al. (32) . For apoptosis assays, after PM were stimulated with LPS (several doses between 5 and 1000 ng/ml) and IFN-␥ (50 -600 units/ml) for 24 h, the macrophages were collected, washed with PBS, and lysed. Isolated DNA (10 -15 g) was electrophoresed in a 1.5% agarose/TAE gel. Apoptosis was also assessed by the TUNEL method using a fluorescein in situ cell death detection kit (Boehringer Mannheim). Antitumor cell activity was measured as described (33) .
Infection with Listeria monocytogenes-Mice were infected with various doses of L. monocytogenes intravenously, and 4 days after infection the number of viable bacteria in spleen and liver homogenates was determined (34) .
Measurement of LDL Oxidation-LDL was prepared according to previously described methods that minimize oxidation and exposure to endotoxin (35) . PM were plated onto 6-well plates (3 ϫ 10 6 cells/well) in DMEM with 10% fetal bovine serum. After 3 h, the macrophages were washed twice with Ham's F-10 medium and then incubated with F-10 medium containing human LDL (0.4 mg/ml, dialyzed at 4°C against PBS without calcium or magnesium in the dark before use) without or with opsonized zymosan (2 mg/ml) for 12 and 24 h. The medium was collected, and LDL oxidation was assayed by measurement of thiobarbituric acid-reactive substances (TBARS) monitored at 532 nm (36) and by formation of an isoprostane oxidant stress marker 8-epi-PGF 2␣ that was extracted by addition of 2 volumes of Folch reagent (CHCl 3 /MeOH, 2:1) from base-hydrolyzed (1.0 M KOH) lipids and quantitated by gas chromatography/mass spectrometry analysis (37) . Values obtained for LDL oxidation in the absence of cells were subtracted from the values obtained with cells.
125
I-LDL Degradation-Iodination of LDL was performed with Na 125 I as described by the iodine monochloride method (38) , and the iodinated LDL (specific radioactivity 60 cpm/ng of LDL protein) was separated from unreacted iodide using a column of Sephadex G-25 (PD-10, Pharmacia Biotech, Inc.) followed by dialysis overnight against PBS at 4°C. Macrophage-modified LDL (24 h incubation) was incubated in degradation assays as described (39) . Briefly, PM from wildtype mice were plated onto 24-well plates (10 6 cells/well) and incubated in DMEM with 10% fetal bovine serum at 37°C overnight. The macrophages were washed twice with DMEM, and the modified 125 I-LDL(10 g/ml) was added to the macrophages. After 5 h, the medium was assayed for trichloroacetic acid-soluble, silver nitrate-soluble (non-iodide) radioactivity as described (39) . Modified 125 I-LDL control incubations in wells containing no cells were performed, and these values were subtracted from the experimental values. After incubations, the macrophages were treated with 0.2 N NaOH and protein-assayed with BioRad reagents.
Statistics-Data are presented as mean Ϯ S.E. Statistical analysis was performed by Instat computer software (Graph Pad, San Diego, CA) using the unpaired t test for single comparisons or analysis of variance for multiple comparisons. p Ͻ 0.05 is considered statistically significant.
RESULTS

Expression of 12/15-Lipoxygenase in Mouse Macrophages-
The murine L-12LO cDNA was isolated previously from RNA of glycogen-elicited peritoneal cell exudates (5) that contain predominantly leukocytes (Ϸ75-80%) and macrophages (Ϸ20 -25%). To identify which cell type expressed the L-12LO gene, we performed in situ hybridization on cytospin peritoneal cell preparations with an antisense L-12LO probe. High level gene expression was detected in about 30 -40% of resident peritoneal macrophages (Fig. 1A) , but no specific expression was detected in elicited leukocytes, including eosinophils (Fig. 1A,  inset) . Hybridization with a sense probe showed no specific signal in any cells (Fig. 1B) . Thioglycollate-elicited macrophages showed approximately the same percentage L-12LO-positive cells and L-12LO-immunoreactive protein as resident macrophages (data not shown). Surprisingly, other populations of mouse macrophages (alveolar and bone marrow-derived) did not show positive hybridization with the antisense L-12LO probe (Fig. 1, C and D) . Incubation of bone marrow-derived macrophages with LPS, LPS ϩ IFN-␥, IL-2, IL-4, IL-13, IL-2 ϩ IFN-␥, tumor necrosis factor-␣ ϩ IFN-␥, or splenocytes stimulated with concanavalin A did not induce L-12LO gene expression as assessed by Western blot analysis (see Fig. 4B and data not shown).
Targeted Disruption of the 12/15-LO Gene-A targeting vector was constructed from a 6.9-kb genomic fragment containing exons 1-8 of the L-12LO gene, and the gene was disrupted within exon 3 (Fig. 2) . The neomycin insertion introduces an in-frame stop codon 109 bases downstream. This construct would be expected to yield a null allele upon homologous re- (A and B) , alveolar macrophages (C), bone marrow-derived macrophages (D), and glycogen-elicited leukocytes (inset A) were prepared as described under "Experimental Procedures" and cytospun onto glass slides. Hybridization was performed with an antisense L-12LO probe (A, C, and D) or sense probe (B). After emulsion overlay, slides were exposed for 7 days, developed and stained with Wright's Giemsa, and brightfield photomicrographs were taken at 400 ϫ magnification. Intense, specific grains are observed over a subset of peritoneal macrophages.
12/15-Lipoxygenase-deficient Mice
combination since the non-heme iron atom ligands that are essential for activity are all located in downstream exons.
The targeting vector was electroporated into D3H embryonic stem cells, and G418/ganciclovir-resistant colonies were picked and expanded for Southern blot analysis. Negative selection afforded a 2.8-fold enrichment. Seven of 288 clones exhibited the expected targeted 10-kb band with a 5Ј external probe (Fig.  3 top) . Upon further examination with neo and 3Ј external probes, 5 clones showed proper targeting (not shown). Embryonic stem cells from 3 clones were injected into 3.5-day C57BL/6 blastocysts, and chimeric mice were generated. One male chimera from clone L1-7 transmitted the disruption through the germ line. Heterozygous offspring were interbred, and homozygous (L-12LO Ϫ/Ϫ ) mice were obtained (Fig. 3 , bottom) at the expected Mendelian frequency indicating that disruption of the L-12LO gene in mice is not essential for development.
To verify that the gene disruption resulted in a null allele, PM were harvested from L-12LO Ϫ/Ϫ mice and wild-type littermate controls, and L-12LO mRNA, protein, and enzyme activities were assessed. Northern blot analysis (Fig. 4A) indicated no evidence for L-12LO mRNA in the deficient mice, but a Ϸ2.7-kb transcript was detected in the control samples. Bone marrow-derived macrophages from wild-type and L-12LO Ϫ/Ϫ mice showed no evidence for the 2.7-kb transcript (Fig. 4A) although glyceraldehyde 3-phosphate dehydrogenase mRNA levels were approximately equivalent in all samples. Protein immunoblotting (Fig. 4B ) revealed a 75-kDa band in wild-type samples, and a similar band of approximately 50% intensity was detected in samples from heterozygous mice. The immunoreactive L-12LO band was absent in macrophages from homozygous mice and in wild-type alveolar and bone marrowderived macrophages (Fig. 4B) .
Altered Arachidonic Acid Metabolism in L-12LO Ϫ/Ϫ Peritoneal Macrophages-Macrophages stimulated with calcium ionophore A23187 from control L-12LO ϩ/ϩ mice were capable of synthesizing products that co-migrated with 12-HETE and 15-HETE standards on RP-HPLC using [ 14 C]arachidonic acid substrate (Fig. 5, A and C) . Leukotriene C 4 (LTC 4 ) was the only 5-lipoxygenase product detected under the incubation conditions used, and cyclooxygenase-derived prostaglandins (PGE 2 , thromboxane B 2 ) were formed as well. In contrast, PM from L-12LO
Ϫ/Ϫ mice made undetectable amounts of 12-HETE and trace quantities of 15-HETE (Fig. 5B and Table I ). To deter- 
FIG. 3. Southern blot analysis to detect homologous recombination in ES cells (top) and to genotype offspring of F 1 intercrosses (bottom)
. ES cell or tail DNA was subjected to StuI/BamHI digestion, electrophoresed, and blotted to nylon membrane. A 5Ј probe external to the targeting vector (probe A; see Fig. 2 ) was used in the top panel, and probe B (see Fig. 2 ) was used in the bottom panel hybridization. Three ES cell clones (L1-7, L1-14, L1-18) out of 18 samples shown here exhibited the expected 10-kb targeted allele. ϩ/ϩ, wild-type; ϩ/Ϫ, heterozygous; Ϫ/Ϫ, homozygous.
FIG. 4. Northern blot (A) and protein immunoblot (B) analyses to verify absence of L-12LO mRNA and protein in homozygous L-12LO
؊/؊ mice. A, total RNA (8 g) from resident peritoneal macrophages (PM) or bone marrow-derived macrophages (BM) was electrophoresed in an agarose/formaldehyde gel, blotted to nitrocellulose, and hybridized with a mouse 1.2-kb 32 P-labeled L-12LO probe (top) or human G3PDH probe (bottom). The blots were exposed for 4 and 8 h, respectively, to Kodak X O-Mat film at Ϫ70°C. B, proteins (5 g) were electrophoresed, blotted to nitrocellulose, and probed with a mouse L-12LO antiserum (1:100 dilution) with detection by enhanced chemiluminescence. The 61-kDa immunoreactive standard (5 ng) is a previously described (5) GST/N-terminal portion of L-12LO. The arrow indicates the positive L-12LO immunoreactive band at 75 kDa. A nonspecific immunoreactive band was observed in AM and BM samples. Ϫ/Ϫ, homozygous; ϩ/Ϫ, heterozygous; ϩ/ϩ, wild-type.
12/15-Lipoxygenase-deficient Mice
mine that only the L-12LO gene was disrupted, and not the P-12LO gene, which is closely linked on chromosome 11 (5), platelets were obtained from both L-12-LO Ϫ/Ϫ mice and littermate controls, and lipoxygenase activity was measured with exogenous arachidonic acid. Both groups of platelets synthesized equivalent amounts of 12-HETE (Fig. 5C) .
LTC 4 production was not altered, but there was a large increase in 5-HETE formation (Fig. 5B and Table I ) in ionophore-stimulated L-12LO Ϫ/Ϫ macrophages. The production of 5-HETE, in addition to LTC 4 , could be blocked by the FLAP inhibitor MK-886 indicating that this product derived from the 5-lipoxygenase pathway (Table I ). The altered metabolic profile was also evident in zymosan-treated cells. In this case, there was not only a loss of 12-HETE formation and elevation of 5-HETE but also a 2-3-fold increase in LTC 4 production (Table  I) . Generally, there was a significant reduction of arachidonic acid metabolism by the L-12LO Ϫ/Ϫ cells; metabolism was not diverted into cyclooxygenase products. To assess whether there was a compensatory change in 5-lipoxygenase or FLAP expression, protein levels were assessed by Western blot analysis. No significant changes were observed (Fig. 6) .
Phenotypic Analysis of L-12LO Ϫ/Ϫ Mice-L-12LO
Ϫ/Ϫ mice grow normally and are fertile. Gross macroscopic examination of external and internal organs revealed no evidence for abnormalities. Sections through pituitary gland, adrenals, pancreas, and spleen (tissues known to contain L-12LO in some species) showed no histological evidence for defects, nor did bone marrow preparations reveal abnormal precursor cells. Macrophages from L-12LO Ϫ/Ϫ mice appeared morphologically normal.
Total blood cell counts were normal, and there was no change in leukocyte differentials (Table II) . The reticulocyte counts in L-12LO Ϫ/Ϫ mice were not significantly different from heterozygous and wild-type littermates (Table II) . Hemoglobin and hematocrit values were not affected. Although no detailed longevity studies have been performed, we noticed three premature deaths in L-12LO Ϫ/Ϫ cages at about 1 year of age and none in wild-type cages housed for the same period of time under identical conditions. The cause of mortality in one mouse appeared to be an undefined infection in the peritoneal cavity.
L-12LO Ϫ/Ϫ mice exhibited similar ear swelling responses to wild-type mice in response to arachidonic acid or phorbol ester challenges in well characterized mouse inflammatory models (40) . Likewise, influx of inflammatory leukocytes into the peritoneal cavity of glycogen-challenged mice was not affected by disruption of the L-12LO gene (data not shown).
Macrophage Function in L-12LO
Ϫ/Ϫ Mice-Since the PM is by far the most abundant site of L-12LO gene expression in mice as assessed by RNase protection assays (data not shown), we carried out several different functional tests in these cells to define a potential role of the 12/15-LO pathway. We hypothesized that the ability of L-12LO to oxygenate directly membrane lipids may affect membrane function and thus alter phagocytic activity or bactericidal function, for example. When IgG-sensitized sheep red blood cells were incubated with resident PM, activated by ionophore or without challenge, rosette formation was significantly diminished in L-12LO Ϫ/Ϫ mice (Fig. 7) . Fc receptor-mediated phagocytosis by resident, thioglycollate-elicited, or LPS/IFN-␥ stimulated macrophages was not significantly altered, however (data not shown). The ability of macrophages to phagocytose Texas Red-conjugated yeast particles and mannose receptor activity (indices of opsoninindependent phagocytic pathway) was not altered nor were antitumor cell macrophage activities (measured as the ability of macrophages to suppress 14 C]arachidonic acid (25 M) for 15 min, extracted, and subjected to RP-HPLC as described under "Experimental Procedures." PGs, prostaglandins. C, peritoneal macrophages (PM) and platelets were prepared from another set of mice and analyzed for HETE production only with 100 M arachidonic acid.
12/15-Lipoxygenase-deficient MiceOxidation and Degradation of LDL by L-12LO
Ϫ/Ϫ Macrophages-Lipoxygenase-mediated oxidation of LDL has been proposed to be a contributing factor to atherogenesis (20, 21) . Accordingly, we incubated PM from L-12LO ϩ/ϩ and L-12LO
Ϫ/Ϫ mice with human LDL for 12 and 24 h and measured the extent of oxidation by two distinct assays. LDL oxidation in the presence of non-stimulated PM measured as production of TBARS or 8-epi-PGF 2␣ was not affected by L-12LO disruption (Fig. 8, A and B). Enhanced oxidation was observed at both time points (Ϸ45%, TBARS, p Ͻ 0.01; Ϸ25%, 8-epi-PGF 2␣ , p Ͻ 0.05) with zymosan-stimulated L-12LO ϩ/ϩ macrophages, but this increase was absent in incubations with L-12LO Ϫ/Ϫ cells (p Ͻ 0.01 and p Ͻ 0.05, respectively; Fig. 8, A and B) . The extent of degradation of macrophage-modified 125 I-LDL as determined by standard methods (39) was not significantly different between unstimulated L-12LO ϩ/ϩ and L-12LO Ϫ/Ϫ cells (2.1 Ϯ 0.25 versus 2.8 Ϯ 0.5 g/mg protein, n ϭ 4).
DISCUSSION
The leukocyte-type 12-lipoxygenase was first characterized in porcine leukocytes (10) . Previously, we had cloned the cDNA for mouse leukocyte-type 12LO from RNA of peritoneal-elicited cells that consisted primarily of leukocytes (5) . Here, we demonstrated by in situ hybridization that the L-12LO gene is not expressed in leukocytes but in a subset of peritoneal macrophages. Approximately 30 -40% of resident, or thioglycollateelicited, peritoneal macrophages showed strong L-12LO-positive hybridization signals. The designation leukocyte-type 12LO, therefore, is a misnomer in mice and a better designation would be "macrophage-type" 12LO. As judged by RNase protection assay, by far the most abundant expression of this gene is in resident PM with lower expression in other tissues like uterus, aorta, trachea, and pituitary gland. 2 Primitive bone marrow-derived macrophages and specifically differentiated alveolar macrophage populations did not express the L-12LO gene in contrast to resident, or elicited, PM. Stimulation of the bone marrow macrophages with numerous activating cytokines and factors proved futile in inducing L-12LO expression. We predicted that interleukin-4 or interleukin-13 might regulate expression of this gene since these factors were shown to enhance expression of the human monocyte 15-LO gene (41, 42) . PM are a functionally and phenotypically heterogeneous population, consisting of immature and terminally differentiated cells (43) . The particular composition of markers unique to the cells expressing L-12LO and the mechanism and factors controlling L-12LO expression in this subset of macrophages will require further studies.
Since L-12LO is most abundantly expressed in mouse PM, our efforts were focused primarily on trying to determine a biological context for L-12LO in macrophage function. The L-12LO gene was disrupted by gene targeting methodology and macrophage L-12LO protein and synthesis of 12-HETE was obliterated. Interestingly, there was a significantly altered pattern of arachidonic acid metabolism in the L-12LO-deficient cells. 5-HETE became a major metabolite in these cells but was not synthesized at all by normal PM. This product was inhibited by the FLAP inhibitor MK-886 indicating it was derived from 5-lipoxygenase. Compensatory FLAP or 5-lipoxygenase expression was not evident, so the most likely explanation is a re-direction of substrate to an alternate lipoxygenase pathway. For zymosan-stimulated cells, the majority of substrate was shunted toward LTC 4 synthesis, with probable saturation of the LTA 4 synthase activity of 5-lipoxygenase. To explain the elevation in 5-HETE in both zymosan-treated and A23187-treated cells, an escape of 5-HPETE from the active site, prior to transformation to LTA 4 , would have to occur. Leukotriene B 4 and the nonenzymatic breakdown products of LTA 4 were very minor products and did not change with L-12LO gene disruption. Alternatively, for unknown reasons and mechanisms, the increased 5-HETE could be an adaptive functional response of the cell to loss of L-12LO expression. Shunting of substrate to the cyclooxygenase pathway did not occur. Thus, an interplay between different lipoxygenase pathways may become important in certain inflammatory situations, or when one pathway is inhibited, and may be relevant to the formation of lipoxins (44) .
Is mouse L-12LO the species equivalent of human and rabbit (41) . This may indicate species variation in LO expression or that L-12LO and 15-LO are not functionally equivalent forms. Based on the high sequence identity of these enzymes and the fact that both enzymes display dual specificity for oxygenation (i.e. both 12-HPETE and 15-HPETE can be formed) and similar substrate preferences, we were very interested to examine the long held view that a LO is responsible for red cell maturation (4, 5, 16 -19) . By virtue of its direct membrane oxygenating capacity, 15-LO action on reticulocyte membranes has been proposed to lead to perturbed structure and enhanced susceptibility to intracellular organelle degradation by proteases (18, 19) . If the hypothesis holds, one would expect that reticulocyte counts would be markedly elevated with a concomitant reduction in mature erythrocytes and a general anemic condition in the deficient mice. However, in L-12LO Ϫ/Ϫ mice the reticulocyte and red blood cell counts and their gross morphology were not significantly different from cells of heterozygous and wild-type littermates. These results could be interpreted four ways. First, mouse L-12LO may not represent the equivalent enzyme found in rabbit reticulocytes. There could be an as of yet uncloned 15-LO in mouse reticulocytes. Second, mouse reticulocytes may not express L-12LO or 15LO. We have found it difficult to verify the presence of L-12LO expression in these cells because it is nearly impossible to eliminate platelet contamination from reticulocyte preparations. 12-HETE was made by these preparations and reverse transcriptase-polymerase chain reaction proved not to be a reliable option in this case. 2 Third, the hypothesis may not be suitable, and this enzyme is not involved in the process of red cell maturation. Fourth, the enzyme may provoke some lipid bilayer remodeling that is non-essential to the overall process of developing mature red cells, or there may be a functionally redundant pathway. Perhaps, some intracellular organelle membrane changes may have been observed at the ultrastructural level.
It does not appear that the L-12LO pathway in macrophages is important or essential for antitumor activity, bactericidal function, nitric oxide production, apoptosis, resistance to infection with Listeria, inflammatory responses, or phagocytosis from both in vivo and in vitro studies. Although only some aspects of these various models or functions have been examined, there are still possibilities of other related functions that have not been tested yet. The initial phase of FcR binding as measured by rosetting of sensitized sheep red cells was diminished in L-12LO Ϫ/Ϫ mice. Although the functional significance of this finding is unclear, it could relate to FcRI occupancy to enhance phospholipase A 2 activity and subsequent metabolism via the arachidonic acid cascade (46) , possibly through L-12LO.
A large body of literature has accumulated around the hypothesis that oxidized LDL contributes to atherogenesis (47, 48) . Thus, oxidation of LDL may convert this lipoprotein into an atherogenic form that leads to inflammatory and proliferative responses characteristic of the atherosclerotic lesion. Evidence for and against the role of a lipoxygenase-mediated initiation or participation in the oxidative process has been presented (49, 50) . 15-LO has been found in foam cell-rich atherosclerotic lesions and co-localizes with epitopes of oxidized LDL (51, 52) . Enhanced levels of lipoperoxides in LDL have been detected in co-incubations with murine fibroblasts that overexpress 15-LO (53) . We found that the zymosan-induced increase in oxidized LDL seen with PM from wild-type mice was absent with L-12LO Ϫ/Ϫ cells (Fig. 8) . The formation of two markers of oxidant stress, the isoprostane, 8-epi-PGF 2␣ (54) and TBARS correlated, although the increment was greater in the TBARS assay. There was no difference in the extent of LDL oxidation between the two experimental groups if cells were not stimulated. These findings would suggest a role of 12/15-LO-mediated oxidation of LDL in some circumstances, possibly in settings of monocyte/macrophage activation in vivo. To examine the in vivo role of the L-12LO pathway in atherogenesis we are currently examining the extent of atherosclerosis in fat-fed mice and in L-12LO Ϫ/Ϫ mice crossed with strains of mice (apoE and LDL receptor-deficient mice) that spontaneously, or by appropriate fat feeding, develop atherosclerosis. These studies should provide a clear-cut answer to the importance of 12/15-LO and atherogenesis.
In summary, we have shown the high level expression of L-12LO in a subset of murine PM and have created mice deficient for this enzyme. L-12LO gene-disrupted cells, challenged with a phagocytic stimulus, exhibit altered metabolism of arachidonic acid. We observed both enhanced generation of leukotrienes and 5-HETE production and differences in LDL oxidation. The biological importance of these observations is under active investigation.
